Not Yet Recruiting
A Phase II Study to Evaluate the Efficacy of UF-KURE19 Cells in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas
NCT07713459
- Conditions
- CAR T Cell Therapy, Diffuse Large B Cell Lymphoma (DLBCL), Follicular B-cell Non-Hodgkin's Lymphoma, +14 more
- Locations
-
Not specified